Showing results (901-910 of 1,505) with videos related to
Sort By:
Pageof 151
Osteoarthritis and Cartilage|February 9, 2016
Defining hip pain trajectories in early symptomatic hip osteoarthritis--5 year results from a nationwide prospective cohort study (CHECK)A N Bastick, S P J Verkleij, J Damen, et al.Pediatric Nephrology (Berlin, Germany)|September 14, 2017
Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney diseaseSahar Fathallah-Shaykh, Dorota Drozdz, Joseph Flynn, et al.Brain Pathology (Zurich, Switzerland)|December 24, 2014
Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspectsHeidi V N Küsters-Vandevelde, Benno Küsters, Adriana C H van Engen-van Grunsven, et al.Breast Cancer Research : BCR|July 27, 2020
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancerEsther H Lips, Anne Benard-Slagter, Mark Opdam, et al.Plos One|April 7, 2016
Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational StudyMarieke van Horck, Ariel Alonso, Geertjan Wesseling, et al.American Journal of Medical Genetics|January 9, 2001
Growth until puberty after in utero exposure to coumarinsD Van Driel, J Wesseling, F R Rosendaal, et al.Radiology|December 9, 2000
Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findingsF Barkhof, A Verrips, P Wesseling, et al.Ultrasonics Sonochemistry|June 22, 2017
Impact of MR-guided boiling histotripsy in distinct murine tumor modelsMartijn Hoogenboom, Dylan C Eikelenboom, Renske J E van den Bijgaart, et al.Neonatology|June 26, 2018
Cardiac Valve Annulus Diameters in Extremely Preterm Infants: A Cross-Sectional Echocardiographic StudyAllard E van Ark, Mirella C Molenschot, Maria H Wesseling, et al.Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|March 24, 2022
Identification of phosphodiesterase type-5 (PDE-5) inhibitors in herbal supplements using a tiered approach and associated consumer riskFelicia Akuamoa, Toine F H Bovee, Ruud van Dam, et al.Pageof 151